Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 8 |
NetGPI | no | yes: 0, no: 8 |
Related structures:
AlphaFold database: A0A3S7WWX6
Term | Name | Level | Count |
---|---|---|---|
GO:0006793 | phosphorus metabolic process | 3 | 9 |
GO:0006796 | phosphate-containing compound metabolic process | 4 | 9 |
GO:0008152 | metabolic process | 1 | 9 |
GO:0009987 | cellular process | 1 | 9 |
GO:0016311 | dephosphorylation | 5 | 9 |
GO:0044237 | cellular metabolic process | 2 | 9 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 9 |
GO:0004721 | phosphoprotein phosphatase activity | 3 | 9 |
GO:0016787 | hydrolase activity | 2 | 9 |
GO:0016788 | hydrolase activity, acting on ester bonds | 3 | 9 |
GO:0016791 | phosphatase activity | 5 | 9 |
GO:0042578 | phosphoric ester hydrolase activity | 4 | 9 |
GO:0140096 | catalytic activity, acting on a protein | 2 | 9 |
GO:0042577 | lipid phosphatase activity | 6 | 1 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 113 | 115 | PF00675 | 0.358 |
CLV_PCSK_KEX2_1 | 113 | 115 | PF00082 | 0.348 |
CLV_PCSK_KEX2_1 | 223 | 225 | PF00082 | 0.283 |
CLV_PCSK_KEX2_1 | 5 | 7 | PF00082 | 0.455 |
CLV_PCSK_PC1ET2_1 | 223 | 225 | PF00082 | 0.283 |
CLV_PCSK_PC1ET2_1 | 5 | 7 | PF00082 | 0.455 |
CLV_PCSK_SKI1_1 | 128 | 132 | PF00082 | 0.282 |
CLV_PCSK_SKI1_1 | 136 | 140 | PF00082 | 0.276 |
CLV_PCSK_SKI1_1 | 50 | 54 | PF00082 | 0.348 |
DEG_SPOP_SBC_1 | 253 | 257 | PF00917 | 0.439 |
DOC_CYCLIN_RxL_1 | 231 | 241 | PF00134 | 0.282 |
DOC_CYCLIN_yCln2_LP_2 | 165 | 171 | PF00134 | 0.170 |
DOC_MAPK_gen_1 | 136 | 145 | PF00069 | 0.283 |
DOC_MAPK_gen_1 | 56 | 65 | PF00069 | 0.257 |
DOC_MAPK_MEF2A_6 | 200 | 207 | PF00069 | 0.348 |
DOC_PP2B_LxvP_1 | 165 | 168 | PF13499 | 0.289 |
DOC_PP4_FxxP_1 | 84 | 87 | PF00568 | 0.331 |
DOC_USP7_MATH_1 | 253 | 257 | PF00917 | 0.416 |
DOC_USP7_UBL2_3 | 124 | 128 | PF12436 | 0.385 |
DOC_USP7_UBL2_3 | 28 | 32 | PF12436 | 0.295 |
DOC_USP7_UBL2_3 | 56 | 60 | PF12436 | 0.348 |
DOC_WW_Pin1_4 | 43 | 48 | PF00397 | 0.348 |
DOC_WW_Pin1_4 | 71 | 76 | PF00397 | 0.305 |
LIG_14-3-3_CanoR_1 | 113 | 123 | PF00244 | 0.311 |
LIG_AP2alpha_1 | 130 | 134 | PF02296 | 0.269 |
LIG_BRCT_BRCA1_1 | 115 | 119 | PF00533 | 0.326 |
LIG_FHA_1 | 115 | 121 | PF00498 | 0.335 |
LIG_FHA_1 | 188 | 194 | PF00498 | 0.333 |
LIG_FHA_1 | 88 | 94 | PF00498 | 0.363 |
LIG_FHA_2 | 161 | 167 | PF00498 | 0.239 |
LIG_LIR_Apic_2 | 248 | 253 | PF02991 | 0.257 |
LIG_LIR_Apic_2 | 82 | 87 | PF02991 | 0.372 |
LIG_LIR_Nem_3 | 122 | 126 | PF02991 | 0.275 |
LIG_LIR_Nem_3 | 215 | 221 | PF02991 | 0.328 |
LIG_LIR_Nem_3 | 82 | 86 | PF02991 | 0.390 |
LIG_Pex14_2 | 119 | 123 | PF04695 | 0.317 |
LIG_Pex14_2 | 130 | 134 | PF04695 | 0.227 |
LIG_SH2_CRK | 225 | 229 | PF00017 | 0.283 |
LIG_SH2_NCK_1 | 225 | 229 | PF00017 | 0.133 |
LIG_SH2_PTP2 | 250 | 253 | PF00017 | 0.330 |
LIG_SH2_STAT5 | 250 | 253 | PF00017 | 0.420 |
LIG_SH2_STAT5 | 61 | 64 | PF00017 | 0.348 |
LIG_SH2_STAT5 | 83 | 86 | PF00017 | 0.304 |
LIG_Sin3_3 | 157 | 164 | PF02671 | 0.348 |
LIG_SUMO_SIM_par_1 | 6 | 11 | PF11976 | 0.292 |
LIG_TYR_ITIM | 31 | 36 | PF00017 | 0.348 |
LIG_TYR_ITIM | 81 | 86 | PF00017 | 0.334 |
LIG_UBA3_1 | 53 | 60 | PF00899 | 0.348 |
MOD_CDK_SPxxK_3 | 43 | 50 | PF00069 | 0.348 |
MOD_CK1_1 | 187 | 193 | PF00069 | 0.352 |
MOD_Cter_Amidation | 48 | 51 | PF01082 | 0.348 |
MOD_GlcNHglycan | 106 | 109 | PF01048 | 0.283 |
MOD_GSK3_1 | 251 | 258 | PF00069 | 0.434 |
MOD_GSK3_1 | 87 | 94 | PF00069 | 0.326 |
MOD_N-GLC_2 | 180 | 182 | PF02516 | 0.348 |
MOD_NEK2_1 | 145 | 150 | PF00069 | 0.247 |
MOD_NEK2_1 | 160 | 165 | PF00069 | 0.231 |
MOD_NEK2_1 | 176 | 181 | PF00069 | 0.246 |
MOD_NEK2_2 | 87 | 92 | PF00069 | 0.383 |
MOD_OFUCOSY | 182 | 188 | PF10250 | 0.348 |
MOD_PK_1 | 224 | 230 | PF00069 | 0.283 |
MOD_PKA_1 | 113 | 119 | PF00069 | 0.358 |
MOD_PKA_2 | 113 | 119 | PF00069 | 0.411 |
MOD_PKA_2 | 251 | 257 | PF00069 | 0.417 |
MOD_Plk_4 | 115 | 121 | PF00069 | 0.293 |
MOD_Plk_4 | 79 | 85 | PF00069 | 0.417 |
MOD_ProDKin_1 | 43 | 49 | PF00069 | 0.348 |
MOD_ProDKin_1 | 71 | 77 | PF00069 | 0.305 |
MOD_SUMO_rev_2 | 116 | 126 | PF00179 | 0.195 |
MOD_SUMO_rev_2 | 44 | 52 | PF00179 | 0.338 |
MOD_SUMO_rev_2 | 64 | 72 | PF00179 | 0.283 |
TRG_ENDOCYTIC_2 | 127 | 130 | PF00928 | 0.278 |
TRG_ENDOCYTIC_2 | 225 | 228 | PF00928 | 0.254 |
TRG_ENDOCYTIC_2 | 33 | 36 | PF00928 | 0.348 |
TRG_ENDOCYTIC_2 | 83 | 86 | PF00928 | 0.348 |
TRG_ER_diArg_1 | 112 | 114 | PF00400 | 0.356 |
TRG_NES_CRM1_1 | 109 | 125 | PF08389 | 0.348 |
TRG_Pf-PMV_PEXEL_1 | 51 | 55 | PF00026 | 0.348 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P4V5 | Leptomonas seymouri | 62% | 100% |
A0A0N1HYX0 | Leptomonas seymouri | 31% | 100% |
A0A0N1PC37 | Leptomonas seymouri | 33% | 100% |
A0A0N1PFC3 | Leptomonas seymouri | 35% | 100% |
A0A3S7X743 | Leishmania donovani | 27% | 100% |
A4HZQ2 | Leishmania infantum | 99% | 100% |
A4I9C5 | Leishmania infantum | 27% | 100% |
E9AVK8 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 90% | 100% |
E9B4C5 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 28% | 100% |
P40289 | Cupriavidus necator (strain ATCC 17699 / DSM 428 / KCTC 22496 / NCIMB 10442 / H16 / Stanier 337) | 29% | 95% |
Q4Q3Q1 | Leishmania major | 29% | 100% |
Q4QBX1 | Leishmania major | 93% | 100% |